<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">GLUTETHIMIDE</span><br/>(gloo-teth'i-mide)<br/><span class="topboxtradename">Doriglute<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic</span><br/><b>Prototype: </b>Secobarbital<br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule III<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Pharmacologic actions similar to those of barbiturates. Can induce hypnosis without producing reliable analgesic, antitussive,
         or anticonvulsant action. Causes less respiratory depression but greater degree of hypotension than barbiturates. Addiction
         liability similar to that of barbiturates.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Significantly suppresses REM sleep; but following drug withdrawal after chronic administration, REM rebound occurs, and patient
         may experience markedly increased dreaming, nightmares, insomnia.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Short-term treatment of insomnia and for sedative effect preoperatively and during first stage of labor. Not indicated for
         routine sedation or persistent insomnia.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Uncontrolled pain; intermittent porphyria; severe hepatic and renal impairment; prolonged administration; lactation; children
         
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Older adult or debilitated patients; prostatic hypertrophy, bladder neck obstruction; pyloroduodenal obstruction, stenosing
         peptic ulcer; narrow-angle glaucoma; hypotension, cardiac arrhythmias; mental depression (particularly in patients with suicidal
         tendencies), history of alcoholism or drug abuse.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Insomnia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250500 mg h.s., may repeat prn but not <br/><span class="indicationtitle">Preoperative Sedation</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 500 mg the night before surgery and 500 mg1 g 1 h before anesthesia<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give 4 h or more before the usual time of arising to avoid residual daytime effects when administered for insomnia.</li>
<li>Withdraw drug gradually, using stepwise dose reduction over a period of several days or weeks. Abrupt withdrawal following
            regular use may produce nausea, vomiting, nervousness, tremors, abdominal cramps, nightmares, insomnia, tachycardia, chills,
            fever, numbness of extremities, dysphagia, delirium, hallucinations, or convulsions.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Acute hypersensitivity reactions. <span class="typehead">CNS:</span> CNS depression in fetus; paradoxic excitement, headache, vertigo. <span class="typehead">GI:</span> Gastric irritation, nausea, drug "hangover," dry mouth. <span class="typehead">Hematologic:</span> Blood dyscrasias. <span class="typehead">Skin:</span> Generalized skin rash (occasionally, purpuric or urticarial), <span class="speceff-life">exfoliative dermatitis (rare).</span> <span class="typehead">Other:</span> Hiccups, blurred vision. <span class="typehead">Acute Overdosage:</span> CNS depression (<span class="speceff-life">coma</span>; depressed reflexes, including corneal reflex; dilated, fixed pupils; hypotension; hypothermia followed by hyperpyrexia;
      tachycardia; <span class="speceff-life">respiratory depression</span>, cyanosis, sudden apnea; decreased intestinal motility, adynamic ileus; facial twitching; intermittent spasticity; flaccid
      paralysis; pulmonary and cerebral edema; renal tubular necrosis; severe infections). <span class="typehead">Chronic Ingestion:</span> Toxic psychosis (slurred speech, impaired memory, inability to concentrate, mydriasis, dry mouth, nystagmus, ataxia, hyporeflexia,
      tremors, peripheral neuropathy). 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol,</b> <span class="classification">barbiturates</span>, other <span class="classification">cns depressants</span> compound depressant effects; <span class="classification">tricyclic antidepressants</span> add to anticholinergic effects; decreases anticoagulant effects of <span class="classification">oral anticoagulants</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Erratic absorption from GI tract. <span class="typehead">Onset:</span> 30 min. <span class="typehead"> Duration:</span> 48 h. <span class="typehead">Distribution:</span> Widely distributed; localizes in adipose tissue, liver, kidney, brain, and bile; crosses placenta; distributed into breast
      milk in small quantities. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Metabolites excreted in urine. <span class="typehead">Half-Life:</span> 1012 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Inform physician of patient's response to drug. Smallest effective dosage should be used for the shortest period of time compatible
            with patient's needs.
         </li>
<li> 							Note: Overdosage of glutethimide is difficult to treat. Patients tend to go in and out of toxicity, possibly because of delayed
            absorption of the drug. 						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report onset of rash or any other unusual symptoms to physician. Discontinuation of drug is indicated if a rash occurs.</li>
<li>Do not drive or engage in other potentially hazardous activities requiring mental alertness for 78 h after drug ingestion.</li>
<li> 							Note: Possible adverse reactions are increased when glutethimide is combined with alcohol or other CNS depressants. 						</li>
<li>Understand that prolonged use of moderate to high doses of glutethimide can produce tolerance and psychologic and physical
            dependence.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>